Home › Funds › Third Point › SPRY

Third Point position in SPRY

SILVERBACK THERAPEUTICS I · Health Care

Third Point reported holding 1,000,000 shares of SPRY (SILVERBACK THERAPEUTICS I) in its Q3 2026 13F filing — a position valued at US$4.3M, representing 0.09% of its reported portfolio and ranking #33 among its reported holdings. Third Point has disclosed SPRY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.00M sh
Reported value held$4.31M
Portfolio Weight0.09%
First reportedQ4 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Third Point's SPRY position evolved

Third Point first disclosed a stake in SPRY in Q4 2025 at 556,237 shares (US$6.5M). The position peaked in Q1 2026 at 1,000,000 shares, worth US$8.0M. Across 4 filings, Third Point increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,000,000 shares valued at US$4.3M. Notable position changes include a 80% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 556.24K $6.48M New
Q1 2026 1.00M $8.03M Add
Q2 2026 1.00M $8.01M Hold
Q3 2026 1.00M $4.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPRY and 13F data

SPRY (SILVERBACK THERAPEUTICS I) is a Health Care company. 19 other funds we track also report a position in SPRY — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$46.8M), ORBIMED ADVISORS LLC (US$35.7M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$32.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPRY

All SPRY fund holders →

FAQ

How long has Third Point held SPRY?

Third Point has disclosed SPRY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Third Point's current position in SPRY?

As of Q3 2026, Third Point holds 1.00M shares of SPRY (SILVERBACK THERAPEUTICS I), valued at $4.31M, representing 0.09% of its reported portfolio and ranking #33.

Has Third Point been buying or selling SPRY?

In the latest 13F filing (Q3 2026), Third Point held unchanged its position in SPRY. The position peaked in Q1 2026 at 1.00M shares.

Which other funds hold SPRY?

Other major institutional holders of SPRY include RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.